Level Up Medical Sales的动态

Lots of good insights and discussion were shared on State of MedTech episode, "Future of Medtech Sales" with Omar M. Khateeb and Steve Bell. The complexity of medical and capital sales is growing and there is a need for larger teams to close deals and successfully launch programs to provide a quality customer experience. SAS companies already take this approach involving a multi-disciplinary team, for example including Solution Engineers up front. They also have roles to maintain and grow relations like Customer Success. https://lnkd.in/gd8-rFJP Compensation for deals with long timelines and many participants needs to evolve. Given the need for a team approach, the whole team needs to win together. Sales deal leading indicators vs lagging indicators need to be focused on. Milestone activities are a great way to track deal progress and will lead to greater motivation and success. #medtech #capitalsales #customerexperience #team #compensation #motivation

“Good growth in both Medtech and Labtech and continued profitability improvement. The companies within AddLife showed strong performance development during the quarter. In Labtech, sales growth recovered as expected and margins remained stable. Sales growth in Medtech was good and margins improved driven by restructuring efforts that are now yielding clear results. Cash flow improved significantly and after the end of the quarter, an acquisition was made in line with our long-term strategy”. Fredrik Dalborg, President and CEO. Summary of the numbers: Organic Growth 7% Net Sales 2,554M SEK (+8%) EBITA SEK 299m (+21%) Operating Cash Flow SEK 195m Read full report here: https://lnkd.in/e8gfZibs #AddLife #Q2report #Q2 #2024 #WeareAddlife

Expanding in the medtech industry is exciting yet complex. At Fair Winds Medical LLC, we offer expert guidance to help you navigate new markets with confidence. Our team provides strategic partnerships, market entry support, and growth acceleration to position your business for success. Discover how we can help drive your success in the competitive medtech landscape. . . . #Medtech #BusinessGrowth #StrategicPlanning #Partnerships #MarketExpansion #BusinessDevelopment #MedtechInnovation #GrowthStrategy #HealthcareTech #SuccessJourney

Are you ready to make 2025 the year your #MedTech business scales faster than ever??? Finding the right #distributors can be one of the toughest parts of growing a MedTech company internationally. But what if connecting with?3 qualified distributors?took only?30 days? At SehaMed?, we have built a network of over 600 specialised distributors actively looking for the latest MedTech solutions for their market. Whether it is expanding to new markets or finding partners who truly understand your technology, we make it simple. Swipe through the carousel to see how our MedTech community drives innovation, efficiencies and outcomes worldwide: ? Save time on partner searches. ? Gain instant exposure to?100+ countries. ? Connect with qualified distributors only. Let’s kick off 2025 with strong partnerships and even stronger results for everyone in our community! #medtech #innovation #internationaltrade

Very insightful blog thats worth your time to check out! AcuityMD

There’s a reason that 73% of the #MedTech executives in our recent survey said they expect their annual revenue from contracts to increase within three years. Unfortunately, most companies don’t have a plan or process that allows them to tap into the potential revenue of these contracts. Read our latest blog to learn how MedTech companies can operationalize their existing contracts and get sales reps the information they need to accelerate sales and increase revenue. Read more - https://bit.ly/40n7ZfZ #MedicalDevices #MedicalSales

?? A Case Study by Blackmore Partners: Stagnation in EBITDA Margins in the MedTech Industry This analysis, prepared by the Business Development Team at Blackmore Partners, highlights a concerning trend among the top 30 global MedTech companies—stagnant EBITDA margins since 2018, with current levels lower than their 2021 peak. ?? This trend suggests that even the largest medical device industry players face significant challenges in maintaining profitability. The situation is likely even more challenging for smaller Medical Tech companies, with stagnant or declining EBITDA margins. ?? What does this mean for the industry? The limited growth in EBITDA margins signals potential opportunities for turnaround and restructuring within the MedTech sector. Companies that effectively address these challenges will be better positioned to thrive in an increasingly competitive market. To understand more about these trends and how your company can navigate them, visit our page: https://buff.ly/4dCcnvs #MedTech #EBITDA #HealthcareIndustry #TurnaroundOpportunities #Restructuring #Profitability #BlackmorePartners

?? A Case Study by Blackmore Partners: Stagnation in EBITDA Margins in the MedTech Industry This analysis, prepared by the Business Development Team at Blackmore Partners, highlights a concerning trend among the top 30 global MedTech companies—stagnant EBITDA margins since 2018, with current levels lower than their 2021 peak. ?? This trend suggests that even the largest medical device industry players face significant challenges in maintaining profitability. The situation is likely even more challenging for smaller Medical Tech companies, with stagnant or declining EBITDA margins. ?? What does this mean for the industry? The limited growth in EBITDA margins signals potential opportunities for turnaround and restructuring within the MedTech sector. Companies that effectively address these challenges will be better positioned to thrive in an increasingly competitive market. To understand more about these trends and how your company can navigate them, visit our page: https://buff.ly/4dCcnvs #MedTech #EBITDA #HealthcareIndustry #TurnaroundOpportunities #Restructuring #Profitability #BlackmorePartners

?? A Case Study by Blackmore Partners: Stagnation in EBITDA Margins in the MedTech Industry This analysis, prepared by the Business Development Team at Blackmore Partners, highlights a concerning trend among the top 30 global MedTech companies—stagnant EBITDA margins since 2018, with current levels lower than their 2021 peak. ?? This trend suggests that even the largest medical device industry players face significant challenges in maintaining profitability. The situation is likely even more challenging for smaller Medical Tech companies, with stagnant or declining EBITDA margins. ?? What does this mean for the industry? The limited growth in EBITDA margins signals potential opportunities for turnaround and restructuring within the MedTech sector. Companies that effectively address these challenges will be better positioned to thrive in an increasingly competitive market. To understand more about these trends and how your company can navigate them, visit our page: https://buff.ly/4dCcnvs #MedTech #EBITDA #HealthcareIndustry #TurnaroundOpportunities #Restructuring #Profitability #BlackmorePartners

The Real Cost of Business as Usual in MedTech Is your MedTech company stuck in an old way of promoting itself? This "business as usual" approach is costing more than you know - outdated approaches to sales just won’t cut it anymore. That's why we have invited an expert with two decades of MedTech sales and marketing experience to show you how to make the change. Join our LinkedIn live on 12 December to hear how Marco Baiguini changed MedTech sales - and won. You'll learn: ? How to use new sales channels that work ? Quick ways to put customers first ? Numbers that show you’re winning ?? Don’t miss out. Join our LinkedIn Live now: https://lnkd.in/dqXiBzFp ?? See why Marco is the perfect guide here: https://lnkd.in/egZwZ7rd #MedTechTransformation #OmnichannelStrategy #DigitalHealth #FutureOfMedTech #CustomerCentricity